FABRE-KRAMER PHARMACEUTICALS, INC.;RUEDIGER, EDWARD H.;YEVICH, JOSEPH P.
发明人:
KRAMER, STEPHEN J.,RUEDIGER, EDWARD H.,FABRE, LOUIS F.,YEVICH, JOSEPH P.
申请号：
HU0301831
公开号：
HU228963B1
申请日:
2000.12.18
申请国别(地区):
HU
年份:
2013
代理人:
摘要：
Bioactive gepirone metabolites, such as 3-OH gepirone (4,4,-dimethyl-3-hydroxy-1-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,6-piperidinedione), and their pharmaceutically acceptable salts and hydrates, can be used to alleviate psychological disorders or the symptoms thereof. The use of these compounds provides advantages over other therapeutic azapirones as they possess superior bioavailability, faster onset of action, and more stable plasma levels when administered to a mammal.
